申请人:MERCK SHARP & DOHME
公开号:WO2012024183A1
公开(公告)日:2012-02-23
Substituted spirocyclic amines of structural formula (I) are selective antagonists of the somatostatin subtype receptor 5 (SSTR5) and are useful for the treatment, control or prevention of disorders responsive to antagonism of SSTR5, such as Type 2 diabetes, insulin resistance, lipid disorders, obesity, atherosclerosis, Metabolic Syndrome, depression, and anxiety.
结构式(I)的螺环胺是生长抑素亚型受体5(SSTR5)的选择性拮抗剂,可用于治疗、控制或预防对SSTR5拮抗敏感的疾病,如2型糖尿病、胰岛素抵抗、脂质紊乱、肥胖、动脉粥样硬化、代谢综合征、抑郁症和焦虑症。